Featured on: Psych Central
Publication date: Apr 14, 2009
Publication date: Apr 14, 2009
CPHPC, a new drug created under the guidance of Professor Mark Pepys in collaboration with the drug company Roche Pharmaceuticals, has shown experimental promise in targeting the Alzheimer's related protein called serum amyloid P component (or SAP), and may be a powerful new weapon in the battle against Alzheimer's Disease.
Read Full Article
Read Full Article
More Alzheimers Articles
Pitt AlzheimerNatural Protein May Slow Alzheimer's
Ask Dr. Gott: Memory Loss Not Always Alzheimer
Battling Inflammation Through Food
Alzheimer's Gene Risk Higher For Those Widowed In Mid Life And Stay Without A Partner
A Simple Balance Test May Predict Cognitive Decline In Alzheimer
Unforgettable Novels On The Subject Of Forgetting
Poor Money Management May Be Early Indicator Of Alzheimer's Disease
People With Early Alzheimer's Fail To Tell What's Important From What's Not
Alzheimer's Disease Increasing As Baby Boomer Generation Retires
